Richard R. Furman, M.D.
Medical Oncology
< Back to Search Results

Richard R. Furman, M.D.

Medical Oncology

Profile Photo of Richard R. Furman, M.D.
Accepts New Patients
Gender: Male
Language: English

About

Specialties and Expertise

Specialties

  • Medical Oncology
  • Hematology

Expertise

  • Chronic Lymphocytic Leukemia
  • Waldenstrom's Macroglobulinemia
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
  • Leukemia
  • Idiopathic Thrombocytopenic Purpura

Biography

Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.

For More Videos, please see below:

Lymphoma Cancer Treatment NY - Weill Cornell

Research

Honors and Awards

Honors and Awards

Charles, Lillian and Betty Neuwirth Clinical Scholar Award, 2004-2006

Credentials

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine (Hematology)
  • American Board of Internal Medicine (Medical Oncology)

Clinical and Academic Positions

  • Attending Physician - NewYork-Presbyterian Hospital
  • Professor of Medicine - Weill Cornell Medical College, Cornell University
  • Morton Coleman, M.D. Distinguished Professor of Medicine - Weill Cornell Medical College, Cornell University
  • Associate Attending Physician - NewYork-Presbyterian Hospital

Education and Training

  • M.D., Mount Sinai School of Medicine, 1993

Insurance

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - HMO
  • AETNA - Medicare
  • AETNA - PPO
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • AgeWell New York
  • Amida Care
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - Blue Connection
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - HMO
  • VNSNY CHOICE - Medicare
  • WellCare of NY
  • WorldWide Medical

Locations and Appointments

News and Media

Videos

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member:
AbbVie Inc.; BeiGene USA; Genentech, Inc.; Janssen Pharmaceutical Company; Pharmacyclics, Inc.
Consultant:
?; AbbVie Inc.; AstraZeneca Pharmaceuticals LP; MorphoSys AG; Sanofi-Aventis
Other Interest:
AstraZeneca Pharmaceuticals LP
Professional Services:
Incyte, Inc.
Speaker/Lecturer:
Janssen Pharmaceutical Company